Fisher HAG - Search Results

1

Clinically Significant Prostate Cancer Detection Following Transrectal and Transperineal Biopsy: Results of the Prostate Biopsy Efficacy and Complications Randomized Clinical Trial.

Mian BM, Feustel PJ, Aziz A, Kaufman RP Jr, Bernstein A, Fisher HAG. Mian BM, et al. Among authors: fisher hag. J Urol. 2024 Jul;212(1):21-31. doi: 10.1097/JU.0000000000003979. Epub 2024 May 3. J Urol. 2024. PMID: 38700844 Clinical Trial.

2

Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate?

Perrotti M, Kaufman RP Jr, Jennings TA, Thaler HT, Soloway SM, Rifkin MD, Fisher HA. Perrotti M, et al. J Urol. 1996 Jul;156(1):106-9. J Urol. 1996. PMID: 8648768 Clinical Trial.

3

Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.

Kallakury BV, Yang F, Figge J, Smith KE, Kausik SJ, Tacy NJ, Fisher HA, Kaufman R, Figge H, Ross JS. Kallakury BV, et al. Cancer. 1996 Oct 1;78(7):1461-9. doi: 10.1002/(sici)1097-0142(19961001)78:7<1461::aid-cncr13>3.0.co;2-y. Cancer. 1996. PMID: 8839552

4

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma.

Ross JS, Sheehan CE, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman RP Jr, Fisher HA, Rifkin MD, Muraca PJ. Ross JS, et al. Cancer. 1997 Jun 1;79(11):2162-70. doi: 10.1002/(sici)1097-0142(19970601)79:11<2162::aid-cncr14>3.0.co;2-u. Cancer. 1997. PMID: 9179063

5

HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization.

Ross JS, Sheehan C, Hayner-Buchan AM, Ambros RA, Kallakury BV, Kaufman R, Fisher HA, Muraca PJ. Ross JS, et al. Hum Pathol. 1997 Jul;28(7):827-33. doi: 10.1016/s0046-8177(97)90157-x. Hum Pathol. 1997. PMID: 9224752

6

The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.

Kallakury BV, Sheehan CE, Ambros RA, Fisher HA, Kaufman RP Jr, Ross JS. Kallakury BV, et al. Cancer. 1997 Aug 15;80(4):753-63. doi: 10.1002/(sici)1097-0142(19970815)80:4<753::aid-cncr15>3.0.co;2-s. Cancer. 1997. PMID: 9264360

7

Telomerase activity in human benign prostate tissue and prostatic adenocarcinomas.

Kallakury BV, Brien TP, Lowry CV, Muraca PJ, Fisher HA, Kaufman RP Jr, Ross JS. Kallakury BV, et al. Diagn Mol Pathol. 1997 Aug;6(4):192-8. doi: 10.1097/00019606-199708000-00003. Diagn Mol Pathol. 1997. PMID: 9360840

8

Intravenous lidocaine speeds the return of bowel function, decreases postoperative pain, and shortens hospital stay in patients undergoing radical retropubic prostatectomy.

Groudine SB, Fisher HA, Kaufman RP Jr, Patel MK, Wilkins LJ, Mehta SA, Lumb PD. Groudine SB, et al. Anesth Analg. 1998 Feb;86(2):235-9. doi: 10.1097/00000539-199802000-00003. Anesth Analg. 1998. PMID: 9459225 Clinical Trial.

9

Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas.

Kallakury BV, Sheehan CE, Ambros RA, Fisher HA, Kaufman RP Jr, Muraca PJ, Ross JS. Kallakury BV, et al. J Clin Oncol. 1998 Apr;16(4):1302-9. doi: 10.1200/JCO.1998.16.4.1302. J Clin Oncol. 1998. PMID: 9552030

10

Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.

Ross JS, Sheehan CE, Ambros RA, Nazeer T, Jennings TA, Kaufman RP Jr, Fisher HA, Rifkin MD, Kallakury BV. Ross JS, et al. Am J Surg Pathol. 1999 Mar;23(3):296-301. doi: 10.1097/00000478-199903000-00008. Am J Surg Pathol. 1999. PMID: 10078920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters